Camlin Fine Sciences Limited reported a consolidated net profit of ₹2,354.32 lakh for the financial year ended March 31, 2026, reversing the net loss of ₹15,811.94 lakh recorded in the previous year. Revenue from operations for the year stood at ₹172,330.81 lakh, an increase from ₹162,868.75 lakh in FY25. The turnaround was driven by a profit of ₹5,507.42 lakh from discontinued operations, primarily due to the derecognition of net liabilities of CFS Europe SpA following its liquidation. The board of directors approved the audited standalone and consolidated financial results during a meeting held on May 26, 2026.

Financial Performance

For the quarter ended March 31, 2026, the company reported a consolidated net profit of 882M rupees compared to a loss of 7M rupees in the same period last year, while quarterly revenue stood at 4.25B rupees versus 4.4B rupees year-on-year. The statutory auditor, M/s. Kalyaniwalla & Mistry LLP, issued an unmodified opinion on the financial statements. Total income for the year rose to ₹175,210.04 lakh from ₹164,384.94 lakh in the previous year, while total expenses increased to ₹176,028.85 lakh from ₹156,989.97 lakh.

The following table summarises the full-year consolidated financial metrics:

The Q4 performance on key metrics is presented below:

Operational Highlights

The company's operational performance for FY26 showed revenue of ₹17,233 million, with EBITDA at ₹1,069 million and an EBITDA margin of 6.20%. The Blends business maintained steady growth with an annual increase of 17%, while the Specialty Ingredients segment contributed significantly to the revenue mix. The newly acquired Vinpai contributed ₹165 million to the total Blends revenue in Q4 FY26. However, the company faced challenges due to prolonged conflicts affecting raw material availability and prices, enhanced logistics costs, and longer delivery times. The contraction in Q4 EBITDA margin to 5% from 13.60% year-on-year reflects these ongoing cost pressures.

Board Appointments and AGM

The board appointed M/s. ABK & Associates as Cost Auditors and M/s. Mahajan & Aibara as the Internal Auditor for FY27. Mr. Pankaj Pandey was appointed as Chief Financial Officer effective August 18, 2026. Upon his joining, Mr. Santosh Parab will be re-designated as President – Strategy and Global CFO. The 33rd Annual General Meeting is scheduled for August 11, 2026.

Camlin Fine Sciences has announced the shutdown of its Diphenol Plant located at Dahej SEZ-II in Gujarat. The decision follows severe constraints on the availability and prices of key raw materials required for the plant, driven by current geopolitical issues and the economic environment. The company had previously reduced capacity utilization at the facility and initiated steps toward its closure.

The shutdown is not expected to impact the production of downstream Straight products, as Hydroquinone has been secured through imports in anticipation of this event. Furthermore, the company maintains adequate inventory of Catechol to support the production of its Aroma products. The facility will remain closed, and any potential restart will be evaluated based on future improvements in the economic and geopolitical landscape. The company is also analyzing the possibility of repurposing the plant.

Separately, a fire incident occurred at the Diphenol Plant on the night of May 23, 2026, around 11:30 p.m. The fire was caused by a leakage of high-temperature thermic fluid, which spread toward the flaking unit. Due to reduced activity levels and ongoing shutdown procedures, the operations team contained the fire within an hour, extinguishing it by 12:30 a.m. on May 24, 2026. No serious injuries were reported, and the Vanillin facility was shut down as a precautionary measure.

A preliminary assessment indicates the incident resulted in the loss of approximately 30 MT of Catechol inventory and damage to the flaker machine, electrical cables, measuring instruments, and insulation. The estimated financial loss is around INR 2 crore. The company confirmed that the loss is adequately covered by insurance and that steps are being initiated to file a claim. Regulatory authorities have been informed, and measures have been taken to prevent environmental hazards.

Following the safety assessment, the company plans to restart Ethyl Vanillin production within the next 48 hours. It does not anticipate any impact on the sales of downstream Straights and Aroma products. The turnover of the Diphenol Plant for the financial year 2024-25 was Rs. 4,352.47 lakh, accounting for 5.06% of the company's total turnover.